Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types -н Panettieri R Jr, Lugogo N, Corren J, Ambrose CS

Бүрэн текст авах

Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma -н Lugogo N, Chipps BE, Panettieri RA Jr, Trudo F, Ambrose CS

Бүрэн текст авах

Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action -н Lindsley AW, Lugogo N, Reeh KAG, Spahn J, Parnes JR

Бүрэн текст авах

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue -н Lugogo N, Gilbert I, Pollack M, Gandhi H, Tkacz J, Lanz MJ

Бүрэн текст авах

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma -н Gurnell M, Radwan A, Bachert C, Lugogo N, Cho SH, Nash S, Zhang H, Khan AH, Jacob-Nara JA, Rowe PJ, Deniz Y

Бүрэн текст авах

Mepolizumab for eosinophilic chronic obstructive pulmonary disease -н Pavord, I, Chanez, P, Criner, G, Kerstjens, H, Korn, S, Lugogo, N, Martinot, J, Sagara, H, Albers, F, Bradford, E, Harris, S, Mayer, B, Rubin, D, Yancey, S, Sciurba, F